We are live on ! Find out more
Aster Capital Management

Aster Capital Management Portfolio holdings

AUM $275M Turnover 72.56%
1-Year Est. Return 18.46%
This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+18.46%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$275M
AUM Growth
-$195M
Cap. Flow
-$180M
Cap. Flow %
-65.37%
Top 10 Hldgs %
10.94%
Holding
1,392
New
584
Increased
169
Reduced
213
Closed
426
Avg Time Held
0.2 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.57M
2
OVV icon
Ovintiv
OVV
+$3.99M
3
KIM icon
Kimco Realty
KIM
+$3.52M
4
ALAB icon
Astera Labs
ALAB
+$3.33M
5
HUT icon
Hut 8
HUT
+$2.16M

Top Sells

Rank Stock Value
1
IYR icon
iShares US Real Estate ETF
IYR
+$11.3M
2
AAPL icon
Apple
AAPL
+$7.75M
3
MSFT icon
Microsoft
MSFT
+$6.82M
4
HON icon
Honeywell
HON
+$6.34M
5
KO icon
Coca-Cola
KO
+$5.38M

Sector Composition

Rank Sector Weight
1 Financials 16.08%
2 Technology 15.72%
3 Industrials 13.9%
4 Healthcare 13.43%
5 Consumer Discretionary 10.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GMRS icon
801
GMR Solutions
GMRS
$668M
$7.82K ﹤0.01%
+812
New +$10.5K
2026 Q3
0 quarters
ANIP icon
802
ANI Pharmaceuticals
ANIP
$1.57B
$7.77K ﹤0.01%
+107
New +$8.24K
2026 Q3
0 quarters
SWIM icon
803
Latham Group
SWIM
$938M
$7.74K ﹤0.01%
+1,243
New +$8.03K
2026 Q3
0 quarters
MIRM icon
804
Mirum Pharmaceuticals
MIRM
$6.24B
$7.52K ﹤0.01%
+88
New +$9.18K
2026 Q3
0 quarters
FFIN icon
805
First Financial Bankshares
FFIN
$4.22B
$7.46K ﹤0.01%
+235
New +$8K
2026 Q3
0 quarters
CNXN icon
806
PC Connection
CNXN
$2.07B
$7.31K ﹤0.01%
81
-108
-57% -$8.83K
2026 Q1
2 quarters
RH icon
807
RH
RH
$2.1B
$7.3K ﹤0.01%
+60
New +$9.5K
2026 Q3
0 quarters
PFSI icon
808
PennyMac Financial
PFSI
$3.03B
$7.1K ﹤0.01%
+115
New +$8.71K
2026 Q3
0 quarters
PTEN icon
809
Patterson-UTI
PTEN
$3.69B
$7.04K ﹤0.01%
+645
New +$7.08K
2026 Q3
0 quarters
TBBK icon
810
Bancorp
TBBK
$1.77B
$6.98K ﹤0.01%
+145
New +$9.13K
2026 Q3
0 quarters
IMVT icon
811
Immunovant
IMVT
$6.73B
$6.96K ﹤0.01%
+206
New +$8.12K
2026 Q3
0 quarters
TRNS icon
812
Transcat
TRNS
$917M
$6.9K ﹤0.01%
+78
New +$6.89K
2026 Q3
0 quarters
BILL icon
813
BILL Holdings
BILL
$5.5B
$6.89K ﹤0.01%
+162
New +$7.47K
2026 Q3
0 quarters
ASTH icon
814
Astrana Health
ASTH
$1.42B
$6.65K ﹤0.01%
+187
New +$7.37K
2026 Q3
0 quarters
ZYME icon
815
Zymeworks
ZYME
$1.86B
$6.57K ﹤0.01%
+248
New +$6.42K
2026 Q3
0 quarters
PRGO icon
816
Perrigo
PRGO
$2.23B
$6.36K ﹤0.01%
+431
New +$5.44K
2026 Q3
0 quarters
PVLA icon
817
Palvella Therapeutics
PVLA
$2.13B
$6.34K ﹤0.01%
+46
New +$6.82K
2026 Q3
0 quarters
TEL icon
818
TE Connectivity
TEL
$60.6B
$6.33K ﹤0.01%
+30
New +$6.2K
2026 Q3
0 quarters
AXSM icon
819
Axsome Therapeutics
AXSM
$7.14B
$6.27K ﹤0.01%
34
-2,423
-99% -$527K
2026 Q1
2 quarters
CWST icon
820
Casella Waste Systems
CWST
$6.26B
$6.19K ﹤0.01%
+77
New +$7.04K
2026 Q3
0 quarters
UPBD icon
821
Upbound Group
UPBD
$1.45B
$6.08K ﹤0.01%
387
+337
+674% +$6.5K
2026 Q1
2 quarters
LNN icon
822
Lindsay Corp
LNN
$1B
$6.04K ﹤0.01%
54
-35
-39% -$4.04K
2026 Q2
1 quarter
PCVX icon
823
Vaxcyte
PCVX
$9.24B
$6.03K ﹤0.01%
+106
New +$6.18K
2026 Q3
0 quarters
NTCT icon
824
NETSCOUT
NTCT
$2.41B
$5.95K ﹤0.01%
+148
New +$5.88K
2026 Q3
0 quarters
PTGX icon
825
Protagonist Therapeutics
PTGX
$8.09B
$5.92K ﹤0.01%
+42
New +$5.99K
2026 Q3
0 quarters

Similar funds

Aster Capital Management's Q3 2026 Portfolio in Review

As of Q3 2026, Aster Capital Management held 1,392 positions worth $275M, down 41% from $470M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Aster Capital Management withdrew a net $180M in Q3 2026, closing 426 positions and reducing 213 holdings. Its most notable exit was iShares US Real Estate ETF, an estimated $11.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Aster Capital Management opened a new position in Alnylam Pharmaceuticals worth $4.43M.

  • Aster Capital Management's largest Q3 2026 buy was Alnylam Pharmaceuticals: 17,949 shares worth $4.43M.
  • Aster Capital Management added most to Simon Property Group in Q3 2026, an estimated $1.93M increase.
  • Aster Capital Management's biggest Q3 2026 reduction was Meta Platforms (Facebook), cutting an estimated $4.29M.
  • Aster Capital Management fully exited iShares US Real Estate ETF in Q3 2026, selling an estimated $11.3M.
  • Aster Capital Management's ten largest holdings make up 11% of its $275M portfolio in Q3 2026.
  • Aster Capital Management opened 584 new positions and closed 426 in Q3 2026.
  • Aster Capital Management's portfolio value fell 41% quarter-over-quarter to $275M.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.